Kerala Ayurveda chairman and AGM
BSE: 530163Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹139.60.
30 Oct: open ₹144.35, high ₹144.35, low ₹137.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹192 Cr2,181st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −257.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −24.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 5.43
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,685
Kerala Ayurveda's chairperson is RAMESH VANGAL, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 28 Sep 2026.
Kerala Ayurveda board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonRAMESH VANGALRelated to the promoter
- Company Secretary and Compliance OfficerBinu Thomas
8 directors4 independent1 executive3 non-executive
- SHILPA KIRAN GUDUDURIndependent · joined Feb 2021 · reappointed Feb 2026 · 67 months as independent · 2 listed boards · 2 as independent · 1 committee seat, 1 as chair
- RAJESH SHARMAIndependent · joined Jun 2022 · reappointed Sep 2022 · 51 months as independent · 1 listed board · 1 as independent · 2 committee seats
- KUNJUPANICKER ANIL KUMARExecutive · joined Jun 2006 · 1 listed board · 1 committee seat
- RAMESH VANGAL · ChairpersonNon-executive · joined Sep 2006 · 1 listed board
- SAIF KHANIndependent · joined Jun 2025 · reappointed Aug 2025 · 15 months as independent · 1 listed board · 1 as independent
- KSHITI RANJAN DASIndependent · joined Oct 2024 · reappointed Jan 2025 · 24 months as independent · 1 listed board · 1 as independent · 1 committee seat
- KODIKANNATH JAYARAJANNon-executive · joined Oct 2024 · 1 listed board · 1 committee seat, 1 as chair
- UTKARSH SINGHNon-executive · joined Mar 2025 · 1 listed board
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- SAMIR DHAWAN, left 9 Jun 2026: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 22 Sep 20265 of 8 present2 independent · 17 days in between
- 4 Sep 20265 of 8 present2 independent · 22 days in between
- 12 Aug 20266 of 8 present2 independent · 47 days in between
- 25 Jun 20264 of 8 present2 independent · 15 days in between
4 earlier meetings
- 9 Jun 20264 of 9 present3 independent · 14 days in between
- 25 May 20266 of 9 present4 independent · 25 days in between
- 29 Apr 20264 of 9 present2 independent · 24 days in between
- 4 Apr 20265 of 9 present2 independent
Audit Committee
Chair SHILPA KIRAN GUDUDUR
KSHITI RANJAN DAS, RAJESH SHARMA
- 22 Sep 20262 of 3 present2 independent · 17 days in between
- 4 Sep 20262 of 3 present2 independent · 22 days in between
- 12 Aug 20262 of 3 present2 independent · 78 days in between
- 25 May 20263 of 3 present3 independent · 25 days in between
2 earlier meetings
- 29 Apr 20262 of 3 present2 independent · 24 days in between
- 4 Apr 20262 of 3 present2 independent
Nomination and remuneration committee
Chair KSHITI RANJAN DAS
RAMESH VANGAL, RAJESH SHARMA
- 12 Aug 20262 of 3 present1 independent · 63 days in between
- 9 Jun 20262 of 3 present1 independent · 40 days in between
- 29 Apr 20262 of 3 present1 independent
Stakeholders Relationship Committee
Chair KODIKANNATH JAYARAJAN
KUNJUPANICKER ANIL KUMAR, RAJESH SHARMA
No meeting listed in the filing.
COMMITTEE OF DIRECTORS
Chair RAMESH VANGAL
UTKARSH SINGH, KUNJUPANICKER ANIL KUMAR
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- G Joseph & AssociatesPeer-review certificate valid to Mar 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Kerala Ayurveda AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.
Annual general meeting, 28 Sep 2026
10,752 shareholders on the register on 21 Sep 2026; present: 0 promoters and 44 others; votes counted by MR BISWAJIT GHOSH / BMP & CO., LLP.The company's voting result
- TO CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026, TOGETHER WITH THE AUDITORS' AND BOARD'S REPORT THEREON.Ordinary98.83% for1.17% against
Against: promoters 0.00% · institutions 0.00% · other public 23.39%
Turnout: all 37.48% · promoters 100.00% · institutions 0.00% · other public 2.91%
- TO APPOINT A DIRECTOR IN PLACE OF MR. RAMESH VANGAL (DIN: 00064018) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT.Ordinary98.83% for1.17% against
Against: promoters 0.00% · institutions 0.00% · other public 23.43%
Turnout: all 37.48% · promoters 100.00% · institutions 0.00% · other public 2.91%
- RATIFICATION OF REMUNERATION PAYABLE TO M/S. SLR & ASSOCIATES, KOCHI, COST AUDITORS OF THE COMPANY:Ordinary98.83% for1.17% against
Against: promoters 0.00% · institutions 0.00% · other public 23.43%
Turnout: all 37.48% · promoters 100.00% · institutions 0.00% · other public 2.91%
- TO CONSIDER AND APPROVE THE ISSUANCE OF 6,55,000 EQUITY SHARES ON PREFERENTIAL BASIS TO KATRA HOLDING PRIVATE LIMITED, PROMOTER GROUP, BY PARTIALLY ADJUSTING THE EXISTING UNSECURED LOAN OF THE COMPANYSpecialPromoters have an interest in it98.83% for1.17% against
Against: promoters 0.00% · institutions 0.00% · other public 23.43%
Turnout: all 37.48% · promoters 100.00% · institutions 0.00% · other public 2.91%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyBSE LimitedSince 20 Aug 2026
Fine Imposed for non-compliance with requirement to appoint a qualified Company Secretary as the Compliance Officer
There was a delay in the appointment of the Company Secretary and Compliance Officer within three months from the date of the vacancy due to the non-availability of a suitable candidate, resulting in delayed compliance with the requirement to appoint a qualified Company Secretary as the Compliance Officer of the Company.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.